Dow Down 2.28% Nasdaq Down 3.02%

Medgenics, Inc. (MDGN)

-NYSE MKT
3.15 Down 0.17(5.12%) 2:05PM EST - Nasdaq Real Time Price
Prev Close:3.32
Open:3.27
Bid:3.15 x 14800
Ask:3.17 x 100
1y Target Est:14.00
Beta:0.401361
Earnings Date:Feb 11 - Feb 15 (Est.)
Day's Range:3.12 - 3.28
52wk Range:3.12 - 10.25
Volume:35,992
Avg Vol (3m):147,855
Market Cap:103.51M
P/E (ttm):N/A
EPS (ttm):-1.63
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MDGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.21
Quarterly EPS Est (Dec-15) :-0.28
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Medgenics, Inc., a clinical stage medical technology company, engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback